26,839 Phibro Animal Health Corporation $PAHC Shares Acquired by Keybank National Association OH

Keybank National Association OH raised its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 16.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 189,576 shares of the company’s stock after buying an additional 26,839 shares during the period. Keybank National Association OH owned about 0.47% of Phibro Animal Health worth $6,775,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Sterling Capital Management LLC boosted its stake in shares of Phibro Animal Health by 864.9% in the third quarter. Sterling Capital Management LLC now owns 714 shares of the company’s stock worth $26,000 after acquiring an additional 640 shares during the last quarter. KBC Group NV purchased a new stake in shares of Phibro Animal Health during the first quarter worth approximately $29,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Phibro Animal Health during the third quarter worth approximately $39,000. Hughes Financial Services LLC raised its stake in Phibro Animal Health by 93.4% in the 3rd quarter. Hughes Financial Services LLC now owns 1,659 shares of the company’s stock valued at $64,000 after purchasing an additional 801 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its stake in Phibro Animal Health by 14.9% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,851 shares of the company’s stock valued at $137,000 after purchasing an additional 498 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of research reports. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday. Weiss Ratings raised shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, November 2nd. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $46.50.

Phibro Animal Health Trading Up 0.9%

Shares of PAHC stock opened at $35.46 on Friday. The company’s 50-day moving average price is $36.80 and its 200-day moving average price is $40.91. The company has a current ratio of 3.20, a quick ratio of 1.28 and a debt-to-equity ratio of 1.70. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of 10.75 and a beta of 0.42. Phibro Animal Health Corporation has a twelve month low of $28.25 and a twelve month high of $60.08.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 4th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.01. Phibro Animal Health had a net margin of 6.66% and a return on equity of 35.88%. The firm had revenue of $386.77 million during the quarter, compared to analysts’ expectations of $382.42 million. As a group, equities analysts predict that Phibro Animal Health Corporation will post 3.48 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 16th. Stockholders of record on Wednesday, November 25th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 25th. This represents a $0.48 annualized dividend and a dividend yield of 1.4%. Phibro Animal Health’s dividend payout ratio is 19.12%.

Phibro Animal Health Profile

Phibro Animal Health Corporation develops and markets products for animal health and nutrition. Its portfolio includes vaccines, medicated feed additives, and nutritional specialty products designed to support the health and productivity of livestock and other animals. The company also supplies trace minerals and related products used in animal nutrition and other applications. Its products serve markets including poultry, cattle, swine, and aquaculture, and are sold to customers in the United States and internationally.